Company Filing History:
Years Active: 2005-2007
Title: Koichi Miyamoto: Innovator in Cyclic Depsipeptide Synthesis
Introduction
Koichi Miyamoto is a distinguished inventor based in Odawara, Japan. He has made significant contributions to the field of biochemistry, particularly in the synthesis of cyclic depsipeptides. With a total of three patents to his name, his work has implications for both scientific research and industrial applications.
Latest Patents
Miyamoto's latest patents include a cyclic depsipeptide synthetase and method for recombinant production. This invention provides an enzyme that synthesizes a cyclic depsipeptide, specifically substance 1022, along with a gene encoding this enzyme. The cyclic depsipeptide synthetase described in the patent comprises an amino acid sequence of SEQ ID NO: 2 or a modified version with one or more modifications that retain its activity. Additionally, he has developed a transformant that produces a secondary metabolite modified with a functional group containing a nitrogen atom. This transformant is engineered to produce a secondary metabolite with a benzene ring skeleton, which is crucial for various biosynthetic pathways.
Career Highlights
Miyamoto is currently employed at Meiji Seika Kaisha, Ltd., where he continues to innovate in the field of biochemistry. His work has not only advanced scientific understanding but also contributed to practical applications in the industry.
Collaborations
Some of his notable coworkers include Naoki Midoh and Takeshi Murakami. Their collaborative efforts have further enhanced the research and development initiatives within their organization.
Conclusion
Koichi Miyamoto's contributions to cyclic depsipeptide synthesis and his innovative patents highlight his role as a leading inventor in the field. His work continues to influence both academic research and industrial practices.